All the information you need about CLINIQUE SEVERINA to develop and secure your business in France

| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-04 | Public | 2021-12-31 | Complete |
| 2021-08-18 | Public | 2020-12-31 | Complete |
| 2020-07-09 | Public | 2019-12-31 | Complete |
| 2019-06-25 | Public | 2018-12-31 | Complete |
| 2018-07-24 | Public | 2017-12-31 | Complete |
| 2017-08-14 | Public | 2016-12-31 | Complete |
| Name | CLINIQUE SEVERINA |
| Siren | 809822612 |
| Closing | 2020-12-31 |
| Registry code | 6901 |
| Registration number | B2021/031304 |
| Management number | 2019B05223 |
| Activity code | 0000Z |
| Closing date n-1 | 2019-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 00 |
| Filing date | 2021-08-18 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | C : Complete |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69002 LYON |
| 1 - Assets (balance sheet) | Gross amount year N | Amortization year N | Net year N | Net year N-1 |
BZ Other receivables | 45.00 | 45.00 | 45.00 | |
CF Cash and cash equivalents | 2 585.00 | 2 585.00 | 2 585.00 | |
CJ TOTAL (II) | 2 631.00 | 2 631.00 | 2 631.00 | |
CO Grand total (0 to V) | 2 631.00 | 2 631.00 | 2 631.00 | |
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 10 000.00 | 10 000.00 | 10 000.00 | |
DH Retained earnings | -24 600.00 | -18 067.00 | -24 600.00 | |
DI RESULTS FOR THE YEAR (Profit or Loss) | -3 338.00 | -6 533.00 | -3 338.00 | |
DL TOTAL (I) | -17 939.00 | -14 600.00 | -17 939.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 17 619.00 | 14 426.00 | 17 619.00 | |
DX Trade payables and related accounts | 2 951.00 | 4 399.00 | 2 951.00 | |
EC TOTAL (IV) | 20 570.00 | 18 825.00 | 20 570.00 | |
EE Grand total (I to V) | 2 631.00 | 4 225.00 | 2 631.00 | |
EG Accrued income and payables due within one year | 20 570.00 | 20 570.00 | ||
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FW Other purchases and external expenses | 3 145.00 | |||
GF Total Operating Expenses (II) | 3 145.00 | |||
GG - OPERATING RESULT (I - II) | -3 145.00 | |||
GT Net expenses on sales of marketable securities | 192.00 | |||
GU Total financial expenses (VI) | 192.00 | |||
GV - FINANCIAL INCOME (V - VI) | -192.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -3 338.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HE Exceptional expenses on management operations | 8.00 | |||
HH Total exceptional expenses (VIII) | 8.00 | |||
HI - EXCEPTIONAL RESULT (VII - VIII) | -8.00 | |||
HM TOTAL EXPENSES (II + IV + VI + VIII + IX + X) | 3 338.00 | 6 533.00 | 3 338.00 | |
HN PROFIT OR LOSS (Total revenue - Total expenses) | -3 338.00 | -6 533.00 | -3 338.00 | |
| 8 - Receivables and payables | Gross amount | Amount within 1 year | Amount 1 to 5 years | Amount more than 5 years |
8B Suppliers and Related Accounts | 2 951.00 | 2 951.00 | 2 951.00 | |
UX Other trade receivables | 46.00 | 46.00 | 46.00 | |
VI Group and Associates | 17 619.00 | 17 619.00 | 17 619.00 | |
VT TOTAL – STATEMENT OF RECEIVABLES | 46.00 | 46.00 | 46.00 | |
VY TOTAL – STATEMENT OF LIABILITIES | 20 571.00 | 20 571.00 | 20 571.00 | |
